Literature DB >> 2845141

Specific interaction between coronavirus leader RNA and nucleocapsid protein.

S A Stohlman1, R S Baric, G N Nelson, L H Soe, L M Welter, R J Deans.   

Abstract

Northwestern blot analysis in the presence of competitor RNA was used to examine the interaction between the mouse hepatitis virus (MHV) nucleocapsid protein (N) and virus-specific RNAs. Our accompanying article demonstrates that anti-N monoclonal antibodies immunoprecipitated all seven MHV-specific RNAs as well as the small leader-containing RNAs from infected cells. In this article we report that a Northwestern blotting protocol using radiolabeled viral RNAs in the presence of host cell competitor RNA can be used to demonstrate a high-affinity interaction between the MHV N protein and the virus-specific RNAs. Further, RNA probes prepared by in vitro transcription were used to define the sequences that participate in such high-affinity binding. A specific interaction occurs between the N protein and sequences contained with the leader RNA which is conserved at the 5' end of all MHV RNAs. We have further defined the binding sites to the area of nucleotides 56 to 65 at the 3' end of the leader RNA and suggest that this interaction may play an important role in the discontinuous nonprocessive RNA transcriptional process unique to coronaviruses.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2845141      PMCID: PMC253863     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  RNA of mouse hepatitis virus.

Authors:  M M Lai; S A Stohlman
Journal:  J Virol       Date:  1978-05       Impact factor: 5.103

2.  Replication of mouse hepatitis virus: negative-stranded RNA and replicative form RNA are of genome length.

Authors:  M M Lai; C D Patton; S A Stohlman
Journal:  J Virol       Date:  1982-11       Impact factor: 5.103

3.  Further characterization of mRNA's of mouse hepatitis virus: presence of common 5'-end nucleotides.

Authors:  M M Lai; C D Patton; S A Stohlman
Journal:  J Virol       Date:  1982-02       Impact factor: 5.103

4.  Characterization of two RNA polymerase activities induced by mouse hepatitis virus.

Authors:  P R Brayton; M M Lai; C D Patton; S A Stohlman
Journal:  J Virol       Date:  1982-06       Impact factor: 5.103

5.  The detection of DNA-binding proteins by protein blotting.

Authors:  B Bowen; J Steinberg; U K Laemmli; H Weintraub
Journal:  Nucleic Acids Res       Date:  1980-01-11       Impact factor: 16.971

6.  Isolation of coronavirus envelope glycoproteins and interaction with the viral nucleocapsid.

Authors:  L S Sturman; K V Holmes; J Behnke
Journal:  J Virol       Date:  1980-01       Impact factor: 5.103

7.  Interactions between coronavirus nucleocapsid protein and viral RNAs: implications for viral transcription.

Authors:  R S Baric; G W Nelson; J O Fleming; R J Deans; J G Keck; N Casteel; S A Stohlman
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

8.  Translational control of vesicular stomatitis virus protein synthesis: isolation of an mRNA-sequestering particle.

Authors:  C A Rosen; H L Ennis; P S Cohen
Journal:  J Virol       Date:  1982-12       Impact factor: 5.103

9.  Sequence of the nucleocapsid gene from murine coronavirus MHV-A59.

Authors:  J Armstrong; S Smeekens; P Rottier
Journal:  Nucleic Acids Res       Date:  1983-02-11       Impact factor: 16.971

10.  Isolation and identification of virus-specific mRNAs in cells infected with mouse hepatitis virus (MHV-A59).

Authors:  W J Spaan; P J Rottier; M C Horzinek; B A van der Zeijst
Journal:  Virology       Date:  1981-01-30       Impact factor: 3.616

View more
  104 in total

1.  Translation from the 5' untranslated region (UTR) of mRNA 1 is repressed, but that from the 5' UTR of mRNA 7 is stimulated in coronavirus-infected cells.

Authors:  S D Senanayake; D A Brian
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  The coronavirus infectious bronchitis virus nucleoprotein localizes to the nucleolus.

Authors:  J A Hiscox; T Wurm; L Wilson; P Britton; D Cavanagh; G Brooks
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

3.  The 5' untranslated region and Gag product of Idefix, a long terminal repeat-retrotransposon from Drosophila melanogaster, act together to initiate a switch between translated and untranslated states of the genomic mRNA.

Authors:  Carine Meignin; Jean-Luc Bailly; Frédérick Arnaud; Bernard Dastugue; Chantal Vaury
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

4.  Proteolytic cleavage of the reovirus sigma 3 protein results in enhanced double-stranded RNA-binding activity: identification of a repeated basic amino acid motif within the C-terminal binding region.

Authors:  J E Miller; C E Samuel
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

5.  A hybrid plant RNA virus made by transferring the noncapsid movement protein from a rod-shaped to an icosahedral virus is competent for systemic infection.

Authors:  W De Jong; P Ahlquist
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

6.  A domain at the 3' end of the polymerase gene is essential for encapsidation of coronavirus defective interfering RNAs.

Authors:  R G van der Most; P J Bredenbeek; W J Spaan
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

7.  Identification of a bovine coronavirus packaging signal.

Authors:  R Cologna; B G Hogue
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

8.  Hemagglutinin-esterase-specific monoclonal antibodies alter the neuropathogenicity of mouse hepatitis virus.

Authors:  K Yokomori; S C Baker; S A Stohlman; M M Lai
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

Review 9.  The molecular biology of coronaviruses.

Authors:  Paul S Masters
Journal:  Adv Virus Res       Date:  2006       Impact factor: 9.937

10.  Ribonucleocapsid formation of severe acute respiratory syndrome coronavirus through molecular action of the N-terminal domain of N protein.

Authors:  Kumar Singh Saikatendu; Jeremiah S Joseph; Vanitha Subramanian; Benjamin W Neuman; Michael J Buchmeier; Raymond C Stevens; Peter Kuhn
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.